Lingjie Ke

519 total citations
19 papers, 431 citations indexed

About

Lingjie Ke is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Lingjie Ke has authored 19 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomedical Engineering, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Lingjie Ke's work include Nanoplatforms for cancer theranostics (6 papers), RNA Interference and Gene Delivery (4 papers) and Ocular Surface and Contact Lens (4 papers). Lingjie Ke is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), RNA Interference and Gene Delivery (4 papers) and Ocular Surface and Contact Lens (4 papers). Lingjie Ke collaborates with scholars based in China and Singapore. Lingjie Ke's co-authors include Yun‐Long Wu, Zibiao Li, Zhiguo Li, Xian Jun Loh, Hongwei Cheng, Caisheng Wu, Xiaoshan Fan, Xiaodong Chen, Pingqiang Cai and Gang Liu and has published in prestigious journals such as Advanced Materials, Nature Communications and Chemical Engineering Journal.

In The Last Decade

Lingjie Ke

18 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingjie Ke China 13 191 137 105 58 50 19 431
Zahra Bakhtiary Iran 9 153 0.8× 191 1.4× 109 1.0× 88 1.5× 47 0.9× 12 455
Guangyu Ji China 7 178 0.9× 140 1.0× 77 0.7× 62 1.1× 44 0.9× 9 571
Shuwen Fu China 10 210 1.1× 159 1.2× 111 1.1× 68 1.2× 34 0.7× 17 397
Olivia L. Lanier United States 10 182 1.0× 150 1.1× 70 0.7× 56 1.0× 29 0.6× 22 447
Yingwen Hu China 11 230 1.2× 295 2.2× 206 2.0× 64 1.1× 42 0.8× 15 568
Hasan Akbaba Türkiye 11 157 0.8× 170 1.2× 222 2.1× 42 0.7× 55 1.1× 34 556
Martina Profeta Italy 13 165 0.9× 127 0.9× 73 0.7× 63 1.1× 29 0.6× 15 399
Kexin Shi China 10 160 0.8× 103 0.8× 144 1.4× 75 1.3× 37 0.7× 24 491
Magali Zeisser Labouebe Switzerland 9 151 0.8× 87 0.6× 124 1.2× 71 1.2× 23 0.5× 12 417
Somayeh Shahreza United Kingdom 8 138 0.7× 156 1.1× 157 1.5× 43 0.7× 69 1.4× 10 452

Countries citing papers authored by Lingjie Ke

Since Specialization
Citations

This map shows the geographic impact of Lingjie Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjie Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjie Ke more than expected).

Fields of papers citing papers by Lingjie Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingjie Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjie Ke. The network helps show where Lingjie Ke may publish in the future.

Co-authorship network of co-authors of Lingjie Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Lingjie Ke. A scholar is included among the top collaborators of Lingjie Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingjie Ke. Lingjie Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zheng, Lan, Ying Chen, Yi Han, et al.. (2024). Thermosensitive Polyhedral Oligomeric Silsesquioxane Hybrid Hydrogel Enhances the Antibacterial Efficiency of Erythromycin in Bacterial Keratitis. Biomaterials Research. 28. 33–33. 2 indexed citations
2.
Zhu, Chunyan, Lingjie Ke, Xiang Ao, et al.. (2023). Injectable Supramolecular Hydrogels for In Situ Programming of Car‐T Cells toward Solid Tumor Immunotherapy. Advanced Materials. 36(5). e2310078–e2310078. 40 indexed citations
3.
Xu, Qiuyun, et al.. (2023). Ciprofloxacin enhances cadmium toxicity to earthworm Eisenia fetida by altering the gut microorganism composition. Environmental Pollution. 333. 122106–122106. 16 indexed citations
4.
Shen, Jie, Lingjie Ke, Qiuping Zhang, et al.. (2022). Cholesterol-stabilized membrane-active nanopores with anticancer activities. Nature Communications. 13(1). 5985–5985. 18 indexed citations
5.
Chen, Ying, Lingjie Ke, Xian Jun Loh, & Yun‐Long Wu. (2022). Design and Gene Delivery Application of Polymeric Materials in Cancer Immunotherapy. 1. 1 indexed citations
6.
Li, Zhiguo, Lingjie Ke, Lijuan Wang, et al.. (2021). Flexible polymeric nanosized micelles for ophthalmic drug delivery: research progress in the last three years. Nanoscale Advances. 3(18). 5240–5254. 43 indexed citations
7.
Fan, Xiaoshan, Lingjie Ke, Hongwei Cheng, et al.. (2021). Enhanced drug retention by anthracene crosslinked nanocomposites for bimodal imaging-guided phototherapy. Nanoscale. 13(35). 14713–14722. 13 indexed citations
8.
Li, Zhiguo, Hongwei Cheng, Lingjie Ke, et al.. (2021). Recent Advances in New Copolymer Hydrogel‐Formed Contact Lenses for Ophthalmic Drug Delivery. ChemNanoMat. 7(6). 564–579. 22 indexed citations
9.
Wu, Caisheng, et al.. (2021). Emerging Biomaterials‐Based Strategies for Inhibiting Vasculature Function in Cancer Therapy. Small Methods. 5(7). e2100347–e2100347. 21 indexed citations
10.
Li, Ziying, Yilin Zheng, Huifang Shi, et al.. (2021). Convenient Tuning of the Elasticity of Self-Assembled Nano-Sized Triterpenoids to Regulate Their Biological Activities. ACS Applied Materials & Interfaces. 13(37). 44065–44078. 25 indexed citations
11.
Ke, Lingjie, et al.. (2021). Thermosensitive Poly(DHSe/PEG/PPG Urethane)-Based Hydrogel Extended Remdesivir Application in Ophthalmic Medication. Pharmaceutics. 14(1). 50–50. 12 indexed citations
12.
Ke, Lingjie, Zhiguo Li, Xiaoshan Fan, et al.. (2021). Cyclodextrin-Based Hybrid Polymeric Complex to Overcome Dual Drug Resistance Mechanisms for Cancer Therapy. Polymers. 13(8). 1254–1254. 17 indexed citations
13.
Shao, Zungui, Lingjie Ke, Qingfeng Wang, et al.. (2021). Directional Transportation in a Self-Pumping Dressing Based on a Melt Electrospinning Hydrophobic Mesh. ACS Biomaterials Science & Engineering. 7(12). 5918–5926. 30 indexed citations
14.
Cheng, Hongwei, Xiaoshan Fan, Enyi Ye, et al.. (2021). Dual Tumor Microenvironment Remodeling by Glucose‐Contained Radical Copolymer for MRI‐Guided Photoimmunotherapy. Advanced Materials. 34(25). e2107674–e2107674. 87 indexed citations
15.
Zheng, Yanfen, et al.. (2020). Enhanced Healing and Antimicrobial Efficacy of Chitosan-g-Polyacrylamide in a Rat Model of Gingival Ulcers. Frontiers in Chemistry. 8. 273–273. 11 indexed citations
16.
Ke, Lingjie, Yun‐Long Wu, & Zibiao Li. (2020). How Effective are Cyclodextrin-Mediated Carriers for Advanced Therapeutic Delivery?. Therapeutic Delivery. 11(9). 537–540. 3 indexed citations
17.
Ke, Lingjie, Pingqiang Cai, Yun‐Long Wu, & Xiaodong Chen. (2020). Polymeric Nonviral Gene Delivery Systems for Cancer Immunotherapy. Advanced Therapeutics. 3(6). 34 indexed citations
18.
19.
Zhang, Yingying, Lu Zhang, Lingjie Ke, et al.. (2019). Dual-responsive nanosystem for precise molecular subtyping and resistant reversal of EGFR targeted therapy. Chemical Engineering Journal. 372. 483–495. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026